Historical record - last NADAC effective date: 11/20/2019
Product Information
ENTECAVIR 0.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.4828 per EA under NDC 65862084190. Its NADAC has been published 180 times since Jun 15, 2016.
FDA first approved this application on Aug 26, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862084190
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/20/2019
Active Ingredients
ENTECAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA206217FDA Approved
8/26/2015
TE Code
AB
On Market Since
8/26/2015
Pharmacological Classes
Price Statistics
The NADAC for ENTECAVIR 0.5 MG TABLET has been published 180 times since Jun 15, 2016, and over the history we have for it it has declined 93.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4828 per EA |
|---|---|
| All-time high | $22.1698 (Jun 15, 2016) |
| All-time low | $1.2853 (Sep 18, 2019) |
| Median price | $4.0630 |
| Average price | $6.2489 |
| Largest weekly change | -36.5% (Nov 21, 2018) |
| Weeks tracked | 180 |
| Tracking since | Jun 15, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-93.3%
Last surveyed Nov 20, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 86% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENTECAVIR 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.4828 per EA (NDC 65862084190), effective Nov 20, 2019.
How has the price of ENTECAVIR 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 93.3%. It has been tracked across 180 weekly CMS publications since Jun 15, 2016.
What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?
Since Jun 15, 2016, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $1.2853 (Sep 18, 2019) to a high of $22.1698 (Jun 15, 2016), with a median of $4.0630 per EA.
Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENTECAVIR 0.5 MG TABLET, is $0.2134 per EA — about 86% below ENTECAVIR 0.5 MG TABLET.
Who manufactures ENTECAVIR 0.5 MG TABLET?
ENTECAVIR 0.5 MG TABLET (NDC 65862084190) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.